Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol

Several therapeutic options are currently available to treat excessive daytime sleepiness (EDS) in patients suffering from narcolepsy or obstructive sleep apnea. However, there are no comparisons between the various wake‐promoting agents in terms of mechanism of action, efficacy, or safety. The goal...

Descripción completa

Detalles Bibliográficos
Autores principales: Krief, Stéphane, Berrebi‐Bertrand, Isabelle, Nagmar, Isabelle, Giret, Martin, Belliard, Simon, Perrin, David, Uguen, Marilyne, Robert, Philippe, Lecomte, Jeanne‐Marie, Schwartz, Jean‐Charles, Finance, Olivier, Ligneau, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381683/
https://www.ncbi.nlm.nih.gov/pubmed/34423920
http://dx.doi.org/10.1002/prp2.855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381683/
https://www.ncbi.nlm.nih.gov/pubmed/34423920
http://dx.doi.org/10.1002/prp2.855

Ejemplares similares